163 related articles for article (PubMed ID: 37756571)
41. Italian cancer burden by broad geographical area.
Baili P; De Angelis R; Casella I; Grande E; Inghelmann R; Francisci S; Verdecchia A; Capocaccia R; Meneghini E; Micheli A
Tumori; 2007; 93(4):398-407. PubMed ID: 17899872
[TBL] [Abstract][Full Text] [Related]
42. Global cancer statistics, 2012.
Torre LA; Bray F; Siegel RL; Ferlay J; Lortet-Tieulent J; Jemal A
CA Cancer J Clin; 2015 Mar; 65(2):87-108. PubMed ID: 25651787
[TBL] [Abstract][Full Text] [Related]
43. Estimation of the number of cancer survivors according to site in Japan.
Hanai A
Jpn J Cancer Res; 1987 Jun; 78(6):537-46. PubMed ID: 3112068
[TBL] [Abstract][Full Text] [Related]
44. [Analysis of cancer incidence and mortality in elderly population in China, 2013].
Chen WQ; Zheng RS; Zhang SW; Zeng HM; Zou XN; He J
Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):60-66. PubMed ID: 28104036
[No Abstract] [Full Text] [Related]
45. Italian cancer figures, report 2010: Cancer prevalence in Italy. Patients living with cancer, long-term survivors and cured patients.
AIRTUM Working Group
Epidemiol Prev; 2010; 34(5-6 Suppl 2):1-188. PubMed ID: 21220827
[TBL] [Abstract][Full Text] [Related]
46. Estimated and observed cancer incidence in Italy: a validation study.
Capocaccia R; Buzzoni C; Grande E; Inghelmann R; Bellù F; Cassetti T; de Dottori M; Donato A; De Lisi V; Falcini F; Federico M; Ferretti S; Fusco M; Giacomin A; Guzzinati S; Mangone L; Piffer S; Rosso S; Sechi O; Tagliabue G; Tumino R; Vercelli M; Vitarelli S
Tumori; 2007; 93(4):387-91. PubMed ID: 17899870
[TBL] [Abstract][Full Text] [Related]
47. 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes:
Milano AF
J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640
[No Abstract] [Full Text] [Related]
48. Planning for the future: cancer incidence projections in Switzerland up to 2019.
Rapiti E; Guarnori S; Pastoors B; Miralbell R; Usel M
BMC Public Health; 2014 Feb; 14():102. PubMed ID: 24484472
[TBL] [Abstract][Full Text] [Related]
49. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.
Ferlay J; Steliarova-Foucher E; Lortet-Tieulent J; Rosso S; Coebergh JW; Comber H; Forman D; Bray F
Eur J Cancer; 2013 Apr; 49(6):1374-403. PubMed ID: 23485231
[TBL] [Abstract][Full Text] [Related]
50. Cost of illness for colorectal cancer in Japan - a time trend and future projections (1996-2035) based on governmental statistics.
Matsumoto K; Hatakeyama Y; Seto K; Onishi R; Hirata K; Wu Y; Hasegawa T
BMC Health Serv Res; 2023 Aug; 23(1):888. PubMed ID: 37608367
[TBL] [Abstract][Full Text] [Related]
51. Partial cancer prevalence in Japan up to 2020: estimates based on incidence and survival data from population-based cancer registries.
Tabata N; Ohno Y; Matsui R; Sugiyama H; Ito Y; Tsukuma H; Oshima A
Jpn J Clin Oncol; 2008 Feb; 38(2):146-57. PubMed ID: 18245517
[TBL] [Abstract][Full Text] [Related]
52. Projections of the cost of cancer care in the United States: 2010-2020.
Mariotto AB; Yabroff KR; Shao Y; Feuer EJ; Brown ML
J Natl Cancer Inst; 2011 Jan; 103(2):117-28. PubMed ID: 21228314
[TBL] [Abstract][Full Text] [Related]
53. Cancer incidence rates in Turkey in 2006: a detailed registry based estimation.
Eser S; Yakut C; Özdemir R; Karakilinç H; Özalan S; Marshall SF; Karaoğlanoğlu O; Anbarcioğlu Z; Üçüncü N; Akin Ü; Özen E; Özgül N; Anton-Culver H; Tuncer M
Asian Pac J Cancer Prev; 2010; 11(6):1731-9. PubMed ID: 21338224
[TBL] [Abstract][Full Text] [Related]
54. Regional estimates of colorectal cancer burden in Italy.
Grande E; Inghelmann R; Francisci S; Verdecchia A; Micheli A; Baili P; Capocaccia R; De Angelis R
Tumori; 2007; 93(4):352-9. PubMed ID: 17899865
[TBL] [Abstract][Full Text] [Related]
55. Cancer incidence and mortality in Brunei Darussalam, 2011 to 2020.
Leong E; Ong SK; Si-Ramlee KA; Naing L
BMC Cancer; 2023 May; 23(1):466. PubMed ID: 37217954
[TBL] [Abstract][Full Text] [Related]
56. Cancer prevalence in European registry areas.
Micheli A; Mugno E; Krogh V; Quinn MJ; Coleman M; Hakulinen T; Gatta G; Berrino F; Capocaccia R;
Ann Oncol; 2002 Jun; 13(6):840-65. PubMed ID: 12123330
[TBL] [Abstract][Full Text] [Related]
57. Projected cancer incidence rates in Bulgaria, 1968-2017.
Hristova L; Dimova I; Iltcheva M
Int J Epidemiol; 1997 Jun; 26(3):469-75. PubMed ID: 9222769
[TBL] [Abstract][Full Text] [Related]
58. Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project.
Hori M; Matsuda T; Shibata A; Katanoda K; Sobue T; Nishimoto H;
Jpn J Clin Oncol; 2015 Sep; 45(9):884-91. PubMed ID: 26142437
[TBL] [Abstract][Full Text] [Related]
59. The updated incidences and mortalities of major cancers in China, 2011.
Chen W; Zheng R; Zeng H; Zhang S
Chin J Cancer; 2015 Sep; 34(11):502-7. PubMed ID: 26370301
[TBL] [Abstract][Full Text] [Related]
60. Cancer incidence and incidence rates in Japan in 2004: based on data from 14 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project.
Matsuda T; Marugame T; Kamo K; Katanoda K; Ajiki W; Sobue T;
Jpn J Clin Oncol; 2010 Dec; 40(12):1192-200. PubMed ID: 20647231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
